Mifepristone for the treatment of uterine leiomyomas: methodological issues and clinical implications.
Erenbourg
Anna
A
Epidemiology and Biostatistics Unit, Department of Obstetrics and Gynaecology, Scientific Direction, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Piccoli
Monica
M
Ronfani
Luca
L
Tamburlini
Giorgio
G
D005260:Female; D006727:Hormone Antagonists / Q000008:administration & dosage*; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy* / Q000473:pathology; D015735:Mifepristone / Q000008:administration & dosage*; D009929:Organ Size / Q000187:drug effects; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014599:Uterus / Q000033:anatomy & histology
D006727:Hormone Antagonists; D015735:Mifepristone